The microneedle drug delivery systems market is estimated at USD 0.8 billion in 2026, is projected to reach USD 1.6 billion by 2036 and is forecast to register a 6.6% CAGR between 2026 and 2036. In 2026, solid microneedles hold 52.6% of product sales and hospitals represent 44.1% within the end user segment.